Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vasopressin antagonists in polycystic kidney disease.

× No keyword cloud information.

15 in total

1. Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD.

Authors: Ao Li; Yuchen Xu; Song Fan; Jialin Meng; Xufeng Shen; Qian Xiao; Yuan Li; Li Zhang; Xiansheng Zhang; Guanqing Wu; Chaozhao Liang; Dianqing Wu
Journal: JCI Insight Date: 2018-03-08

Review 2. Renal cystic diseases: diverse phenotypes converge on the cilium/centrosome complex.

Authors: Lisa M Guay-Woodford
Journal: Pediatr Nephrol Date: 2006-07-06 Impact factor: 3.714

3. Unmasking of undiagnosed pre-existing central diabetes insipidus after renal transplantation.

Authors: David D W Kim; Ian M Holdaway
Journal: Pituitary Date: 2012-03 Impact factor: 4.107

Review 4. Expanding the role of vasopressin antagonism in polycystic kidney diseases: From adults to children?

Authors: Peter Janssens; Caroline Weydert; Stephanie De Rechter; Karl Martin Wissing; Max Christoph Liebau; Djalila Mekahli
Journal: Pediatr Nephrol Date: 2017-04-28 Impact factor: 3.714

5. Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease.

Authors: Romina Mancinelli; Antonio Franchitto; Shannon Glaser; Antonella Vetuschi; Julie Venter; Roberta Sferra; Luigi Pannarale; Francesca Olivero; Guido Carpino; Gianfranco Alpini; Paolo Onori; Eugenio Gaudio
Journal: Lab Invest Date: 2016-08-29 Impact factor: 5.662

6. Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists.

Authors: Julie Perucca; Daniel G Bichet; Pascale Bardoux; Nadine Bouby; Lise Bankir
Journal: J Am Soc Nephrol Date: 2008-07-02 Impact factor: 10.121

Review 7. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.

Authors: Tevfik Ecder; Robert W Schrier
Journal: Nat Rev Nephrol Date: 2009-04 Impact factor: 28.314

Review 8. Vasopressin antagonists in polycystic kidney disease.

Authors: Vicente E Torres
Journal: Semin Nephrol Date: 2008-05 Impact factor: 5.299

Review 9. Therapeutic potential of vasopressin receptor antagonists.

Authors: Farhan Ali; Maya Guglin; Peter Vaitkevicius; Jalal K Ghali
Journal: Drugs Date: 2007 Impact factor: 9.546

Review 10. Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies.

Authors: O Ibraghimov-Beskrovnaya; N Bukanov
Journal: Cell Mol Life Sci Date: 2008-02 Impact factor: 9.261